Ad is loading...
MENU

LPCN Lipocine Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products

Industry Biotechnology
LPCN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
LPCN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LPCN is expected to report earnings to rise 962.50% to -42 cents per share on August 09

Lipocine LPCN Stock Earnings Reports
Q2'23
Est.
$-0.43
Q1'23
Missed
by $0.01
Q4'22
Missed
by $0.31
Q3'22
Missed
by $0.48
Q2'22
Missed
by $0.64
The last earnings report on May 11 showed earnings per share of -3 cents, missing the estimate of -2 cents. With 13.63K shares outstanding, the current market capitalization sits at 25.19M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
17
Web
https://www.lipocine.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBLY17.290.37
+2.19%
Mobileye Global
CBZ79.431.54
+1.98%
CBIZ
DAIO2.600.02
+0.78%
Data I/O Corp
GABC45.080.14
+0.31%
German American Bancorp
FATE2.07-0.15
-6.76%
Fate Therapeutics

LPCN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
+6.16%
SPRY - LPCN
63%
Loosely correlated
-1.25%
IPA - LPCN
43%
Loosely correlated
-9.72%
ZNTL - LPCN
36%
Loosely correlated
+1.60%
TARA - LPCN
30%
Poorly correlated
-0.87%
CRSP - LPCN
27%
Poorly correlated
-2.05%
More